Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BYImmunity, inflammation and disease

Rheumatoid Arthritis and Thrombocytopenia: Causal Evidence and Prognostic Implications From Observational and Mendelian Randomization Analyzes.

  1. 1School of Clinical Medicine, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  2. 2Pudong Gongli Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  3. 3Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.

Abstract

Background

Rheumatoid arthritis (RA) is a systemic autoimmune disease associated with hematological abnormalities, and we aimed to investigate the clinical significance and causal relationship of thrombocytopenia (TP) in RA. We integrated observational data with genetic approaches, characterized the clinical features of RA patients with TP, and evaluated their prognostic implications.Materials and methods

Data from the National Health and Nutrition Examination Survey were used to analyze clinical characteristics and survival outcomes of RA patients. Survey-weighted Cox regression models were applied to evaluate the association between TP and mortality. Two-sample Mendelian randomization (MR) analysis was performed to evaluate the causal relationship between RA and TP.Results

Among 2667 RA participants with available platelet measurements, 135 had TP (< 150 × 10⁹/L). In the common complete-case sample, TP remained associated with higher all-cause mortality after full survey-weighted adjustment (HR 1.92, 95% CI 1.17-3.16; p = 0.009). Lower serum albumin and higher urinary albumin concentration were also associated with mortality in the fully adjusted model. In the MR analysis using 52 SNPs, fixed-effect IVW yielded OR 1.054 (95% CI 1.002-1.108; p = 0.042), but alternative estimators were not significant and the MR-Egger intercept indicated directional pleiotropy (p = 0.0016).Discussion

Thrombocytopenia was associated with poorer survival among RA participants, whereas MR did not provide robust evidence for a causal effect of RA liability on thrombocytopenia. These findings warrant further prospective validation.

Related

  1. Bidirectional Mendelian randomization analysis reveals the causal relationship between rheumatoid arthritis and acute sinusitis
    Rui Hu, Yunwang Zhang, Yi Zeng +3
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Severe Immune Thrombocytopenia Associated With Newly Diagnosed Rheumatoid Arthritis and Complicated by a Spontaneous Presacral Haematoma: A Case Report.
    Nyein Su Win, Wine Ohn Chit
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Single-cell eQTL Mendelian randomization reveals the monocyte-associated PRKCB–CTSL axis as a candidate regulatory pathway and potential therapeutic target in rheumatoid arthritis
    Pengli Wang, Guohang Shen, Wenhua Liao +6
    Clinical RheumatologyPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  4. Identification of SLC15A3 as a shared prognostic biomarker for AML and COVID-19 via integrative bioinformatics, machine learning and Mendelian randomization
    Miaomiao Liu, Junhui Zhu, Huan Li
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  5. The Bidirectional Relationship Between Rheumatoid Arthritis and Periodontitis: Current Evidence and Clinical Implications
    Naif A Alwithanani
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{wu2026rheumatoid,
  title = {{Rheumatoid Arthritis and Thrombocytopenia: Causal Evidence and Prognostic Implications From Observational and Mendelian Randomization Analyzes.}},
  author = {Yejun Wu and Yuyang Cai and Anzhen Yang and Shuying Zhang and Liangyu Xu and Yanting Xie and Peng Zhao},
  journal = {Immunity, inflammation and disease},
  year = {2026},
  month = nov,
  doi = {10.1002/iid3.70551},
  url = {https://europepmc.org/article/MED/43012374},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Rheumatoid Arthritis and Thrombocytopenia: Causal Evidence and Prognostic Implications From Observational and Mendelian Randomization Analyzes.
AU  - Yejun Wu
AU  - Yuyang Cai
AU  - Anzhen Yang
AU  - Shuying Zhang
AU  - Liangyu Xu
AU  - Yanting Xie
AU  - Peng Zhao
PY  - 2026
DA  - 2026/11/01
JO  - Immunity, inflammation and disease
DO  - 10.1002/iid3.70551
UR  - https://europepmc.org/article/MED/43012374
AB  - Background  Rheumatoid arthritis (RA) is a systemic autoimmune disease associated with hematological abnormalities, and we aimed to investigate the clinical significance and causal relationship of thrombocytopenia (TP) in RA. We integrated observational data with genetic approaches, characterized the clinical features of RA patients with TP, and evaluated their prognostic implications.Materials and methods  Data from the National Health and Nutrition Examination Survey were used to analyze clinical characteristics and survival outcomes of RA patients. Survey-weighted Cox regression models were applied to evaluate the association between TP and mortality. Two-sample Mendelian randomization (MR) analysis was performed to evaluate the causal relationship between RA and TP.Results  Among 2667 RA participants with available platelet measurements, 135 had TP (< 150 × 10⁹/L). In the common complete-case sample, TP remained associated with higher all-cause mortality after full survey-weighted adjustment (HR 1.92, 95% CI 1.17-3.16; p = 0.009). Lower serum albumin and higher urinary albumin concentration were also associated with mortality in the fully adjusted model. In the MR analysis using 52 SNPs, fixed-effect IVW yielded OR 1.054 (95% CI 1.002-1.108; p = 0.042), but alternative estimators were not significant and the MR-Egger intercept indicated directional pleiotropy (p = 0.0016).Discussion  Thrombocytopenia was associated with poorer survival among RA participants, whereas MR did not provide robust evidence for a causal effect of RA liability on thrombocytopenia. These findings warrant further prospective validation.
SN  - 2050-4527
ER  -